{"id":"W2041065149","doi":"10.2147/ndt.s4716","title":"Pregabalin for the management of partial epilepsy","year":2008,"lang":"en","type":"article","venue":"Neuropsychiatric Disease and Treatment","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"UCB Pharma; Valeant Pharmaceuticals International; Eisai; Sanofi","keywords":"Medicine; Pregabalin; Tolerability; Adverse effect; Epilepsy; Anesthesia; Somnolence; partial seizures; Refractory (planetary science); Placebo; Adjunctive treatment; Anticonvulsant; Internal medicine; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002819849,0.0005468801,0.0007102164,0.0005677757,0.0003129283,0.0003076823,0.000421733,0.0006040803,0.004618152],"category_scores_gemma":[0.000556608,0.00007904618,0.0006144942,0.0005873442,0.0003638801,0.0002816965,0.0003532469,0.001485783,0.00167758],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00026074,"about_ca_system_score_gemma":0.0004342286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005859045,"about_ca_topic_score_gemma":0.00188252,"domain_scores_codex":[0.9998868,0.00003426513,0.00001479548,0.00001474232,0.00003133568,0.0000180733],"domain_scores_gemma":[0.9997998,0.00005827799,0.00006916439,0.00001117036,0.00001409956,0.00004759242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004721579,0.0008788771,0.002289051,0.003478225,0.0002989753,0.00173959,0.00007868258,0.0002980307,0.01474275,0.0008584728,0.01315141,0.9574644],"study_design_scores_gemma":[0.02946066,0.05327718,0.1772223,0.006667784,0.002149059,0.09040705,0.0004655496,0.002949066,0.0298156,0.008884725,0.5984164,0.0002845223],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1041994,0.8684115,0.003309763,0.006470871,0.001046418,0.0003061616,0.0003195653,0.0003425291,0.01559394],"genre_scores_gemma":[0.4293104,0.5420696,0.007725455,0.007182644,0.002006296,0.0005639832,0.001160013,0.00007105296,0.009910541],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004618152,"threshold_uncertainty_score":0.01544923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03024683155161127,"score_gpt":0.2941612955495008,"score_spread":0.2639144639978895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}